231
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Development of a New Patient-Reported Medication Adherence Instrument: Concerns Influencing Medication Adherence

, , , , ORCID Icon &
Pages 1991-2007 | Published online: 09 Sep 2021

References

  • Cea-Calvo L, Marín-Jiménez I, de Toro J, et al. Different associations of intentional and non-intentional non-adherence behaviors with patient experience with healthcare and patient beliefs in medications: a survey of patients with chronic conditions. Patient Prefer Adherence. 2020;14:2439–2450. doi:10.2147/PPA.S281985
  • Margolis Center. Medication adherence: landscape, strategies, and evaluation methods: meeting summary. 2019; Available from: https://healthpolicy.duke.edu/sites/default/files/2020-07/Medication%20Adherence_Public%20Meeting%20Summary.pdf. Accessed 3 December, 2020.
  • Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:217047. doi:10.1155/2015/217047
  • Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. doi:10.1056/NEJMra050100
  • Benjamin RM. Medication adherence: helping patients take their medicines as directed. Public Health Rep. 2012;127(1):2–3. doi:10.1177/003335491212700102
  • Pellegrin KL, Lee E, Uyeno R, Ayson C, Goo R. Potentially preventable medication-related hospitalizations: a clinical pharmacist approach to assessment, categorization, and quality improvement. J Am Pharm Assoc (2003). 2017;57(6):711–716. doi:10.1016/j.japh.2017.06.019
  • DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–209. doi:10.1097/01.mlr.0000114908.90348.f9
  • World Health Organization. Adherence to long-term therapies: evidence for action. 2003; Available from: https://www.who.int/chp/knowledge/publications/adherence_full_report.pdf?ua=1. Accessed 3 December, 2020.
  • Kvarnström K, Airaksinen M, Liira H. Barriers and facilitators to medication adherence: a qualitative study with general practitioners. BMJ Open. 2018;8(1):e015332. doi:10.1136/bmjopen-2016-015332
  • Food and Drug Administration. Guidance for Industry patient-reported outcome measures: use in medical product development to support labeling claims. 2009; Available from: http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf. Accessed December 8, 2020.
  • FDA. FDA patient-focused drug development guidance series for enhancing the incorporation of the patient’s voice in medical product development and regulatory decision making. 2020; Available from: https://www.fda.gov/drugs/development-approval-process-drugs/fda-patient-focused-drug-development-guidance-series-enhancing-incorporation-patients-voice-medical. Accessed 18 February, 2020.
  • Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. doi:10.1186/2046-4053-4-1
  • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. doi:10.1136/bmj.b2700
  • Popay J, Roberts H, Sowden A, et al. Guidance on the conduct of narrative synthesis in systematic reviews. A product from the ESRC methods programme Version; 2006. Available form: http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.178.3100&rep=rep1&type=pdf. Accessed December 8, 2020.
  • Bajorek B, Saxton B, Anderson E, Chow CK. Patients’ preferences for new versus old anticoagulants: a mixed-method vignette-based study. Eur J Cardiovasc Nurs. 2018;17(5):429–438. doi:10.1177/1474515117739618
  • Barrett AD, DiBeneditti D, Phatak H, Masseria C, Kamble S. Focus groups exploring experiences with and preferences for oral anticoagulants in people with nonvalvular atrial fibrillation. Abstract PCV68 Presented at the 21st Annual meeting of the International Society for Pharmacoeconomic and Outcomes Research 21–25 May, Washington, DC, USA. Value Health. 2016;19(3):A51.
  • Bartoli-Abdou JK, Patel JP, Crawshaw J, et al. Exploration of adherence and patient experiences with DOACs one year after switching from vitamin-K antagonists- insights from the switching study. Thromb Res. 2018;162:62–68. doi:10.1016/j.thromres.2017.12.021
  • Clarkesmith DE, Lip GYH, Lane DA. Patients’ experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: a qualitative study. Thromb Res. 2017;153:19–27. doi:10.1016/j.thromres.2017.03.002
  • Ferguson C, Inglis SC, Newton PJ, Middleton S, Macdonald PS, Davidson PM. Barriers and enablers to adherence to anticoagulation in heart failure with atrial fibrillation: patient and provider perspectives. J Clin Nurs. 2017;26(23–24):4325–4334. doi:10.1111/jocn.13759
  • Gumbinger C, Holstein T, Stock C, Rizos T, Horstmann S, Veltkamp R. Reasons underlying non-adherence to and discontinuation of anticoagulation in secondary stroke prevention among patients with atrial fibrillation. Eur Neurol. 2015;73(3–4):184–191. doi:10.1159/000371574
  • Mas Dalmau G, Sant Arderiu E, Enfedaque Montes MB, Solà I, Pequeño Saco S, Alonso Coello P. Patients’ and physicians’ perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic review. BMC Fam Pract. 2017;18(1):3. doi:10.1186/s12875-016-0574-0
  • Müller S, Kohlmann T, Wilke T. Validation of the Adherence Barriers Questionnaire - an instrument for identifying potential risk factors associated with medication-related non-adherence. BMC Health Serv Res. 2015;15:153. doi:10.1186/s12913-015-0809-0
  • Pandya EY, Bajorek B. Factors Affecting Patients’ Perception On, and Adherence To, Anticoagulant Therapy: anticipating the Role of Direct Oral Anticoagulants. The Patient. 2017;10(2):163–185. doi:10.1007/s40271-016-0180-1
  • Ruiz MA, González-Porras JR, Aranguren JL, et al. Development and validation of a new questionnaire measuring treatment satisfaction in patients with non-valvular atrial fibrillation: SAFUCA(®). Qual Life Res. 2017;26(3):767–778. doi:10.1007/s11136-016-1474-4
  • Vaanholt MC, Weernink MG, Jzerman MJ, von Birgelen C, van Til JA. A qualitative exploration of reasons for (non-)adherence to oral anticoagulant therapy in patients with atrial fibrillation. Abstract PCV110 presented at the 20TH International Society for Pharmacoeconomic and Outcomes Research (ISPOR) Annual European Congress, 4–8 November Glasgow, Scotland, UK. Value Health. 2017;20(9):A620.
  • Vaanholt MCW, Weernink MGM, von Birgelen C. Perceived advantages and disadvantages of oral anticoagulants, and the trade-offs patients make in choosing anticoagulant therapy and adhering to their drug regimen. Patient Educ Couns. 2018;101(11):1982–1989. doi:10.1016/j.pec.2018.06.019
  • Weernink MGM, Vaanholt MCW, Groothuis-Oudshoorn CGM, von Birgelen C. Patients’ Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis. Am J Cardiovasc Drugs. 2018;18(6):493–502. doi:10.1007/s40256-018-0293-0
  • Alami S, Boutron I, Desjeux D, et al. Patients’ and practitioners’ views of knee osteoarthritis and its management: a qualitative interview study. PLoS One. 2011;6(5):e19634. doi:10.1371/journal.pone.0019634
  • Carpenter D, Blalock S, DeVellis R. Conflicting medication information is associated with worse medication adherence. Abstract P169 Presented at the Society for Clinical and Translational Science Annual Meeting 18–20 April, Washington, DC, USA. Clin Transl Sci. 2012;5(2):29.
  • Dockerty T, Latham SK, Smith TO. Why don’t patients take their analgesics? A meta-ethnography assessing the perceptions of medication adherence in patients with osteoarthritis. Rheumatol Int. 2016;36(5):731–739. doi:10.1007/s00296-016-3457-8
  • Geryk LL, Blalock S, DeVellis RF, Morella K, Carpenter DM. Associations between patient characteristics and the amount of arthritis medication information patients receive. J Health Commun. 2016;21(10):1122–1130. doi:10.1080/10810730.2016.1222036
  • Geryk LL, Blalock SJ, DeVellis RF, Jordan JM, Han PK, Carpenter DM. Medication-related self-management behaviors among arthritis patients: does attentional coping style matter? Open Rheumatol J. 2016;10:60–70. doi:10.2174/1874312901610010060
  • Laba TL, Brien JA, Fransen M, Jan S. Patient preferences for adherence to treatment for osteoarthritis: the MEdication Decisions in Osteoarthritis Study (MEDOS). BMC Musculoskelet Disord. 2013;14:160. doi:10.1186/1471-2474-14-160
  • Manias E, Claydon-Platt K, McColl GJ, Bucknall TK, Brand CA. Managing complex medication regimens: perspectives of consumers with osteoarthritis and healthcare professionals. Ann Pharmacother. 2007;41(5):764–771. doi:10.1345/aph.1H623
  • Myung G, Harada ND, Fong SL, Aquino-Beaton C, Fang MA. Characterization of social stigma in rheumatic diseases and correlation with quality of life and medication adherence. Abstract 2107 Presented at the 2014 ACR/ARHP Annual Meeting 14–19 November, Boston, MA, USA. Arthritis Rheumatol. 2014;66(10):S921.
  • Pouli N, Das Nair R, Lincoln NB, Walsh D. The experience of living with knee osteoarthritis: exploring illness and treatment beliefs through thematic analysis. Disabil Rehabil. 2014;36(7):600–607. doi:10.3109/09638288.2013.805257
  • Sale JE, Gignac M, Hawker G. How “bad” does the pain have to be? A qualitative study examining adherence to pain medication in older adults with osteoarthritis. Arthritis Rheum. 2006;55(2):272–278. doi:10.1002/art.21853
  • Selten EM, Vriezekolk JE, Geenen R, et al. Reasons for treatment choices in knee and hip osteoarthritis: a qualitative study. Arthritis Care Res. 2016;68(9):1260–1267. doi:10.1002/acr.22841
  • Warner LM, Schüz B, Aiken L, et al. Interactive effects of social support and social conflict on medication adherence in multimorbid older adults. Soc Sci Med. 2013;87:23–30. doi:10.1016/j.socscimed.2013.03.012
  • Wiederkehr S, De Bock E, Chekroun M, Arnould B. Adherence issues in osteoarthritis: how can acceptance measurement help understanding patients’ concerns and working on solutions? Abstract PMS46 presented at the International SOciety for Pharmacoeconomics and Outcomes research (ISPOR) Real-World, Digital Health, and the New Landscape for Health Decisions Making Conference 19–23 May, Baltimore, MD, USA. Value Health. 2018;21:S198–S199.
  • Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008;8:45. doi:10.1186/1471-2288-8-45
  • McHorney CA, Bricker DE, Kramer AE, et al. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: I. Conceptual foundation and item development. Dysphagia. 2000;15(3):115–121. doi:10.1007/s004550010012
  • van Someren MW, Barnard Y, Sandberg J. The Think Aloud Method: A Practical Guide to Modelling Cognitive Processes. London, United Kingdom: Academic Press; 1994.
  • Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101. doi:10.1191/1478088706qp063oa
  • Muhr T. User’s Manual for ATLAS.ti 5.0, ATLAS.ti Scientific Software Development. Berlin, Germany: Scientific Software Development GmbH; 2004.
  • McHorney CA. The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin. 2009;25(1):215–238. doi:10.1185/03007990802619425